Cue Biopharma appointed Dominic Borie as chief medical officer and R&D head as it advances CUE-221 (Phase 2 data expected Q3 2026) and CUE-401 (Phase 1 start Q4 2026). He brings over 20 years of immunology and clinical development experience. The company recently raised $50M to support clinical development.
Three FcRn inhibitors are approved for generalized myasthenia gravis, with a head-to-head trial of efgartigimod and nipocalimab underway. Emerging therapies including telitacicept, gefurulimab, and CAR-T cell therapy (KYV-101) show promise, while Immunovant's batoclimab failed TED trials.
Researchers at McMaster University said their SyntheMol-RL AI model designed a new antibiotic candidate called synthecin. In mouse wound infection models, the topical compound was highly effective against drug-resistant Staphylococcus aureus.
The FDA approved Bracco's Vueway for neonates and infants at half the standard gadolinium dose, accepted Bayer's gadoquatrane application for a 60% dose reduction, and granted Breakthrough Device designation to Radiology Partners' AI chest X-ray tool.
Researchers at Stanford and Harvard are developing nasal spray vaccines offering broad protection against respiratory infections, with early animal and phase 1 human trials showing safety and potential efficacy.
National Institutes of Health Director Jay Bhattacharya will serve as acting director of the Centers for Disease Control and Prevention following Jim O'Neill's departure. Bhattacharya will oversee both agencies simultaneously as the CDC faces significant instability.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07778706 |
Intervention on Mathematical Problem-Solving Skills |
NOT_YET_RECRUITING | NA |
| NCT07768488 |
Evaluating Food Messaging Campaigns for Young Adults |
NOT_YET_RECRUITING | NA |
| NCT07768462 |
Young Adult Food Messaging Experiment |
NOT_YET_RECRUITING | NA |
| NCT07767448 |
Characterization of Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events |
NOT_YET_RECRUITING | NA |
| NCT07758647 |
NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) Systems |
NOT_YET_RECRUITING | NA |
| NCT07756138 |
Filsuvez in Moderate-to-Severe Epidermolysis Bullosa Simplex |
NOT_YET_RECRUITING | PHASE2 |
| NCT07744425 |
Shortwave Infrared Surgical Imaging Device Study |
ENROLLING_BY_INVITATION | |
| NCT07743489 |
RB-PDT for Fusarium Keratitis: The LUMIERE Study |
NOT_YET_RECRUITING | PHASE3 |
| NCT07741955 |
Empowering Veterans in Research Effectively Using Virtual Engagement Tools |
NOT_YET_RECRUITING | NA |
| NCT07740148 |
Human-Created vs AI-generated Art on Immediate Psychological Responses |
RECRUITING | NA |
